Expert Interview
A second look: Digging in to the Phase 2b data presented at the AAC Conference for Merck's oral PCSK9 inhibitor, MK-0616, in patients with hypercholesterolemia
Ticker(s): MRKInstitution: Columbia University
- Chief of vascular surgery at NewYork-Presbyterian/Columbia University Irving Medical Center.
- A vascular surgeon-scientist, Dr. Patel is highly skilled in the full range of vascular disorders that can lead to stroke, renal issues, intestinal problems, and peripheral arterial disease.
- Interest in clinical outcomes research and has served as principal investigator of several studies to evaluate open and minimally invasive repairs of complex aortic aneurysms.
- Manages 10-15 patients monthly with Paroxysmal supraventricular tachycardia (PSVT)
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
